发布求助
文献互助 智能选刊 最新文献

Medicom Conference Report ASH 2023最新文献

筛选
英文 中文
Undetectable MRD on maintenance venetoclax, acalabrutinib, and obinutuzumab in the majority of R/R CLL participants 大多数 R/R CLL 参与者在接受 Venetoclax、acalabrutinib 和 obinutuzumab 治疗后，MRD 检测不到
Medicom Conference Report ASH 2023 Pub Date : 2024-02-07 DOI: 10.55788/11dff369
Robert van den Heuvel
{"title":"Undetectable MRD on maintenance venetoclax, acalabrutinib, and obinutuzumab in the majority of R/R CLL participants","authors":"Robert van den Heuvel","doi":"10.55788/11dff369","DOIUrl":"https://doi.org/10.55788/11dff369","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"23 20","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139893344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term efficacy and safety of iptacopan in PNH with anaemia 伊帕考潘对伴有贫血的 PNH 的长期疗效和安全性
Medicom Conference Report ASH 2023 Pub Date : 2024-02-07 DOI: 10.55788/a06f74c6
Robert van den Heuvel
{"title":"Long-term efficacy and safety of iptacopan in PNH with anaemia","authors":"Robert van den Heuvel","doi":"10.55788/a06f74c6","DOIUrl":"https://doi.org/10.55788/a06f74c6","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"18 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Momelotinib beats controls regarding transfusion outcomes in myelofibrosis 在骨髓纤维化患者输血效果方面，莫米替尼优于对照组
Medicom Conference Report ASH 2023 Pub Date : 2024-02-07 DOI: 10.55788/195a47af
Robert van den Heuvel
{"title":"Momelotinib beats controls regarding transfusion outcomes in myelofibrosis","authors":"Robert van den Heuvel","doi":"10.55788/195a47af","DOIUrl":"https://doi.org/10.55788/195a47af","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"126 3-4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel risk assessment model acts on increasing hospital-acquired venous thromboembolism rates among children 新型风险评估模型有助于提高儿童的医院获得性静脉血栓栓塞率
Medicom Conference Report ASH 2023 Pub Date : 2024-02-07 DOI: 10.55788/e518c218
Robert van den Heuvel
{"title":"Novel risk assessment model acts on increasing hospital-acquired venous thromboembolism rates among children","authors":"Robert van den Heuvel","doi":"10.55788/e518c218","DOIUrl":"https://doi.org/10.55788/e518c218","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"61 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blinatumomab reduces toxicity in the consolidation phase in paediatric high-risk B-cell ALL Blinatumomab可降低儿科高危B细胞ALL巩固治疗阶段的毒性
Medicom Conference Report ASH 2023 Pub Date : 2024-02-07 DOI: 10.55788/19866a5c
Robert van den Heuvel
{"title":"Blinatumomab reduces toxicity in the consolidation phase in paediatric high-risk B-cell ALL","authors":"Robert van den Heuvel","doi":"10.55788/19866a5c","DOIUrl":"https://doi.org/10.55788/19866a5c","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"277 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139896072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TRANSFORM-1: High spleen volume reduction rates for navitoclax plus ruxolitinib in myelofibrosis TRANSFORM-1：纳维替克联合鲁索利替尼治疗骨髓纤维化的脾脏体积缩小率较高
Medicom Conference Report ASH 2023 Pub Date : 2024-02-07 DOI: 10.55788/3462662c
Robert van den Heuvel
{"title":"TRANSFORM-1: High spleen volume reduction rates for navitoclax plus ruxolitinib in myelofibrosis","authors":"Robert van den Heuvel","doi":"10.55788/3462662c","DOIUrl":"https://doi.org/10.55788/3462662c","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"40 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Favourable QoL and bleeding outcomes for rilzabrutinib in ITP 利扎鲁替尼治疗ITP具有良好的QoL和出血疗效
Medicom Conference Report ASH 2023 Pub Date : 2024-02-07 DOI: 10.55788/2d100bb8
Robert van den Heuvel
{"title":"Favourable QoL and bleeding outcomes for rilzabrutinib in ITP","authors":"Robert van den Heuvel","doi":"10.55788/2d100bb8","DOIUrl":"https://doi.org/10.55788/2d100bb8","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"2 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139896055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DALIAH: Peginterferon-α head-to-head against hydroxyurea in MPN DALIAH：Peginterferon-α与羟基脲在骨髓增生性白血病中的正面交锋
Medicom Conference Report ASH 2023 Pub Date : 2024-02-07 DOI: 10.55788/38079b44
Robert van den Heuvel
{"title":"DALIAH: Peginterferon-α head-to-head against hydroxyurea in MPN","authors":"Robert van den Heuvel","doi":"10.55788/38079b44","DOIUrl":"https://doi.org/10.55788/38079b44","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"29 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SYMPATICO: Ibrutinib plus venetoclax boosts PFS in R/R mantle cell lymphoma SYMPATICO：伊布替尼加venetoclax可改善R/R套细胞淋巴瘤的PFS
Medicom Conference Report ASH 2023 Pub Date : 2024-02-07 DOI: 10.55788/2e1c8f3f
Robert van den Heuvel
{"title":"SYMPATICO: Ibrutinib plus venetoclax boosts PFS in R/R mantle cell lymphoma","authors":"Robert van den Heuvel","doi":"10.55788/2e1c8f3f","DOIUrl":"https://doi.org/10.55788/2e1c8f3f","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"95 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Axatilimab may present a new therapeutic strategy in chronic GvHD 阿沙替利单抗可能为慢性风湿性关节炎提供一种新的治疗策略
Medicom Conference Report ASH 2023 Pub Date : 2024-02-07 DOI: 10.55788/c1876370
Robert van den Heuvel
{"title":"Axatilimab may present a new therapeutic strategy in chronic GvHD","authors":"Robert van den Heuvel","doi":"10.55788/c1876370","DOIUrl":"https://doi.org/10.55788/c1876370","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"111 3-4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信